4//SEC Filing
Mango Paul 4
Accession 0001062993-22-014979
CIK 0001835567other
Filed
Jun 15, 8:00 PM ET
Accepted
Jun 16, 4:13 PM ET
Size
8.4 KB
Accession
0001062993-22-014979
Insider Transaction Report
Form 4
Mango Paul
Director
Transactions
- Award
Restricted Stock Units
2022-06-14+100,000→ 100,000 total→ Class A Common Stock (100,000 underlying) - Award
Restricted Stock Units
2022-06-14+100,000→ 100,000 total→ Class A Common Stock (100,000 underlying)
Footnotes (3)
- [F1]Each restricted stock unit represents a contingent right to receive one share of PEAR common stock.
- [F2]The restricted stock units shall vest and settle (x) as to 100% of the shares upon the Reporting Person's cessation of Service Relationship (as defined in the Issuer's 2021 Stock Option and Incentive Plan) that qualifies as a "separation from service" within the meaning of Section 409A of the Internal Revenue Code (the "Separation Date"), provided that the Separation Date occurs on or after June 14, 2025 or (y) if the Separation Date occurs prior to June 14, 2025, the restricted stock units shall vest and settle only as to the percentage of the shares equal to the product of (a) the number of twelve month periods between the grant date and the Separation Date multiplied by (b) 33.33 1/3 (and for the avoidance of doubt, if the Separation Date occurs prior to June 14, 2023, the restricted stock units shall expire unvested).
- [F3]The restricted stock units shall vest and settle as to 100% of the shares on the Separation Date, provided that the Separation Date occurs on or after June 14, 2023 (and for the avoidance of doubt, if the Separation Date occurs prior to June 14, 2023, the restricted stock units shall expire unvested).
Issuer
Pear Therapeutics, Inc.
CIK 0001835567
Entity typeother
Related Parties
1- filerCIK 0001932759
Filing Metadata
- Form type
- 4
- Filed
- Jun 15, 8:00 PM ET
- Accepted
- Jun 16, 4:13 PM ET
- Size
- 8.4 KB